Reevaluation of RINT1 as a breast cancer predisposition gene-Reference-Cited by-同舟云学术

Reevaluation of RINT1 as a breast cancer predisposition gene

Published:2016-08-20 Issue:2 Volume:159 Page:385-392
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Li Na,Thompson Ella R.,Rowley Simone M.,McInerny Simone,Devereux Lisa,Goode David,Investigators LifePool,Wong-Brown Michelle W.,Scott Rodney J.,Trainer Alison H.,Gorringe Kylie L.,James Paul A.,Campbell Ian G.

Funder

National Breast Cancer Foundation

Cancer Australia

National Health and Medical Research Council

Victorian Cancer Agency

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-016-3944-3.pdf

Reference19 articles.

1. Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW, Thorne H, Barnes DR, Li J, Ellul J, Philip GK, Antill YC, James PA, Trainer AH, Mitchell G, Campbell IG (2012) Exome sequencing identifies rare deleterious mutations in DNA repair genes fancc and blm as potential breast cancer susceptibility alleles. PLoS Genet 8(9):e1002894

2. Hilbers FS, Wijnen JT, Hoogerbrugge N, Oosterwijk JC, Collee MJ, Peterlongo P, Radice P, Manoukian S, Feroce I, Capra F, Couch FJ, Wang X, Guidugli L, Offit K, Shah S, Campbell IG, Thompson ER, James PA, Trainer AH, Gracia J, Benitez J, van Asperen CJ, Devilee P (2012) Rare variants in XRCC2 as breast cancer susceptibility alleles. J Med Genet 49(10):618–620.

3. Park DJ, Tao K, Le Calvez-Kelm F, Nguyen-Dumont T, Robinot N, Hammet F, Odefrey F, Tsimiklis H, Teo ZL, Thingholm LB, Young EL, Voegele C, Lonie A, Pope BJ, Roane TC, Bell R, Hu H, Shankaracharya Huff CD, Ellis J, Li J, Makunin IV, John EM, Andrulis IL, Terry MB, Daly M, Buys SS, Snyder C, Lynch HT, Devilee P, Giles GG, Hopper JL, Feng BJ, Lesueur F, Tavtigian SV, Southey MC, Goldgar DE (2014) Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers. Cancer Discov 4(7):804–815

4. Miosge LA, Field MA, Sontani Y, Cho V, Johnson S, Palkova A, Balakishnan B, Liang R, Zhang Y, Lyon S, Beutler B, Whittle B, Bertram EM, Enders A, Goodnow CC, Andrews TD (2015) Comparison of predicted and actual consequences of missense mutations. Proc Natl Acad Sci USA 112(37):E5189–E5198

5. Sawyer S, Mitchell G, McKinley J, Chenevix-Trench G, Beesley J, Chen XQ, Bowtell D, Trainer AH, Harris M, Lindeman GJ, James PA (2012) A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 30(35):4330–4336

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted sequencing for hereditary breast and ovarian cancer in BRCA1/2-negative families reveals complex genetic architecture and phenocopies;Human Genetics and Genomics Advances;2024-07

2. RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer;Cancer Research;2021-02-02

3. Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition;Genes, Chromosomes and Cancer;2020-11-10

4. RINT1 Bi-allelic Variations Cause Infantile-Onset Recurrent Acute Liver Failure and Skeletal Abnormalities;The American Journal of Human Genetics;2019-07

5. “Decoding hereditary breast cancer” benefits and questions from multigene panel testing;The Breast;2019-06